Catchable cancer rising in US? Here's all you need to know

US oncologists are increasingly concerned about a rise in cancers linked to infections, particularly those associated with sexually transmitted diseases like HPV. Research shows a significant increase in cervical cancer cases among young adults an...

IANS
US oncologists are increasingly worried about a rise in cancers that can be transmitted through infections, particularly those linked to common sexually transmitted diseases (STDs).

A recent report highlights that while rates of major cancers like lung, breast, and kidney have remained steady, cancers tied to the human papillomavirus (HPV) are on the increase in America.

Research from the American Association for Cancer Research shows a 17.5% increase in cervical cancer cases among individuals aged 30-34 from 2012 to 2019. Additionally, mouth and throat cancers caused by HPV have been rising across all age groups.


HPV is a highly contagious sexually transmitted virus affecting over 42 million Americans. It is associated with about 1.2% of cancers in men and 2.5% in women annually in the US. It can lead to cervical, head, neck, throat, and anal cancers. The virus spreads primarily through sexual contact.

The virus has 200 types, with 12 linked to cancer. HPV contributes to cancer by weakening the immune system, causing chronic inflammation, and changing cell behavior. It is responsible for nearly 99.7% of cervical cancers, 90% of anal cancers, and 70% of mouth and throat cancers.

Pathogens like HPV, hepatitis viruses, and H. pylori bacteria are known to be linked to various types of cancer, influenced by global factors like sanitation and healthcare practices.
ADVERTISEMENT

The HPV vaccine, approved by the FDA in 2006, is available for both boys and girls starting at age 11. It is believed to prevent nearly 90% of HPV-related cancers, according to a 2020 study from Sweden. A 2024 study in Scotland found that early vaccination programs have led to zero new cases of cervical cancer this year.

However, the report states, “Despite clear evidence demonstrating that the vaccine reduces cervical cancer incidence, vaccine uptake in the US has been poor.”

In 2024, approximately 2 million cancer cases are expected to be diagnosed in the US. Of these, HPV-related cancers—of the mouth, head, throat, cervix, and genitals—account for 1.2% of all cancers in men and 2.5% in women. This includes about 11,500 new cases of cervical cancer and roughly 4,000 deaths from the disease.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › World News › Catchable cancer rising in US? Here's all you need to know
Text Size:AAA
Success
This article has been saved

*

+